Stock-Based Compensation

6 Months Ended

Dec. 31, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock-Based Compensation

(11) Stock-Based Compensation

Stock Option Activity Summary

The Company’s stock option activity for the six months ended December 31, 2021 is as follows:

	Shares (In thousands)			Weighted Average Exercise Price
Outstanding at June 30, 2021		275		$	5.25
Granted		—			—
Exercised		—			—
Canceled or expired		(122	)		4.96
Outstanding at December 31, 2021		153		$	5.41

The aggregate intrinsic value of options exercisable at December 31, 2021 was $0, as the fair value of the Company’s common stock is less than the exercise prices of these options. The remaining stock-based compensation expense of $1 thousand related to stock options will be recognized over a weighted-average period of 0.78 years.

The table below details the Company’s stock options outstanding as of December 31, 2021:

Range of exercise prices	Number Outstanding (In thousands)		Options Outstanding Weighted- Average Remaining Contractual Life (Years)		Weighted- Average Exercise Price		Number Exercisable (In thousands)		Options Exercisable Weighted- Average Exercise Price
$1.85 – 2.83		13		6.74	$	2.08		10	$	2.15
$5.00 – 5.85		88		5.36		5.55		88		5.55
$6.00 – 6.00		52		0.64		6.00		52		6.00
$1.85 – 6.00		153		3.87	$	5.41		150	$	5.49

Compensation costs recognized related to stock option awards were $0 for each of the three months ended December 31, 2021, and 2020 and $1 thousand for each of the six months ended December 31, 2021 and 2020.

Restricted Stock

The Company’s restricted stock activity for the six months ended December 31, 2021, is as follows:

	Shares (In thousands)			Weighted Average Grant-Date Fair Value
Outstanding at June 30, 2021	$	2,023		$	2.05
Granted		—			—
Vested		(28	)		3.39
Canceled or expired		—			—
Outstanding at December 31, 2021	$	1,995		$	2.03

Stock compensation expenses related to restricted stock were $439 thousand and $46 thousand for the three months ended December 31, 2021, and 2020, respectively, and $797 thousand and $90 thousand for the six months ended December 31, 2021 and 2020, respectively. The remaining stock-based compensation expense of $3.0 million related to restricted stock awards granted will be recognized over a weighted-average period of 2.23 years.